Stem Cell Clinical Trials - Premier Regenerative Stem Cell
Stem Cell Therapy,regenerative therapy,stem cell treatment, joint treatment,back treatment,spine therapy, joint therapy
page-template,page-template-full_width,page-template-full_width-php,page,page-id-15677,page-child,parent-pageid-15672,ajax_updown_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-7.4,wpb-js-composer js-comp-ver-5.1,vc_responsive

Clinical Trials & Studies


NFL former and current athletes with shoulder pain or shoulder injuries. Contact Kandace Stolz at

FDA Clinical Trial – Adult Stem Cell Therapy to Treat Back Pain

Mesoblast, a leader in adult stem cell product research, has developed a process to immunoselect the mesenchymal precursor cells (stem cells) from adult bone marrow mononuclear cells and then expand these stem cells in culture to produce allogenic MPCs (NeoFuse™). These expanded stem cells have been shown to retain the mesenchymal cell capacity for differentiation into bone, cartilage, and adipose tissue in-vitro and to regenerate bone in-vivo.

Your name (required)

Your email (required)

Phone number

Reason for interest in this study

Request a Consultation